羚锐制药

- 600285

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
羚锐制药(600285) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入90,904.69331,147.26250,678.08170,066.2578,864.82
营业收入90,904.69331,147.26250,678.08170,066.2578,864.82
二、营业总成本69,649.78268,330.35198,821.63134,726.3762,276.47
营业成本22,183.2488,438.7463,604.3441,975.5118,506.53
营业税金及附加1,328.864,639.373,458.512,364.661,091.98
销售费用41,410.85150,378.34114,887.4579,146.1537,634.90
管理费用3,489.6017,420.7412,671.858,428.373,504.49
财务费用-802.09-3,512.03-2,445.69-1,516.81-581.95
研发费用2,039.3110,965.196,645.164,328.492,120.52
资产减值损失----------
公允价值变动收益73.2812.075.873.804.20
投资收益685.562,015.431,077.67664.87414.52
其中:对联营企业和合营企业的投资收益-0.40-38.47-22.70-7.953.86
汇兑收益----------
三、营业利润22,082.6465,630.7253,909.6936,548.5217,063.00
加:营业外收入4.5843.4431.8927.564.31
减:营业外支出5.21369.74153.90130.7372.02
其中:非流动资产处置损失----------
四、利润总额22,082.0265,304.4253,787.6836,445.3416,995.29
减:所得税费用3,049.158,492.857,169.094,742.612,577.26
五、净利润19,032.8656,811.5746,618.5931,702.7314,418.03
归属于母公司所有者的净利润19,037.8656,810.9346,618.2031,698.1114,424.64
少数股东损益-5.000.640.394.62-6.61
六、每股收益
基本每股收益(元/股)0.34001.01200.83000.56300.2600
稀释每股收益(元/股)0.33601.00300.82300.55700.2540
七、其他综合收益-4,943.46-2,563.24287.47-15.5920.43
八、综合收益总额14,089.4154,248.3346,906.0731,687.1414,438.46
归属于母公司所有者的综合收益总额14,092.8354,237.4146,898.7431,679.4614,443.83
归属于少数股东的综合收益总额-3.4210.927.327.68-5.37
下载全部历史数据到excel中 返回页顶